Pharmacologic IRE1 Activation Rewires Cholesterol Metabolism to Suppress TH17 Differentiation

T helper 17 (TH17) cells are a subset of CD4⁺ T cells that coordinate immune responses against extracellular bacterial and fungal pathogens. Dysregulation of TH17 cell responses drives excessive inflammation and contributes to the development of chronic inflammatory and autoimmune diseases, including psoriasis, inflammatory bowel disease, and multiple sclerosis. Here, we demonstrate that pharmacologic activation of the IRE1 signaling arm of the unfolded protein response (UPR) selectively reduces differentiation of TH17 cells without impacting the differentiation of other helper T cell subsets. We show that IRE1 activation suppresses TH17 differentiation by limiting intracellular cholesterol in differentiating TH17 cells through the increased degradation of the rate-limiting cholesterol biosynthesis enzyme HMGCR. Our findings identify IRE1 as a metabolic checkpoint regulating cholesterol biosynthesis in differentiating TH17 cells and demonstrate that its pharmacological activation suppresses TH17 differentiation, highlighting a potential therapeutic strategy for limiting TH17-driven inflammatory diseases.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-16
DOI
https://doi.org/10.64898/2026.11.12.765150
Primary Topic
Psoriasis: Treatment and Pathogenesis
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Pharmacologic IRE1 Activation Rewires Cholesterol Metabolism to Suppress TH17 Differentiation

William A. Dion, Sergei Kutseikin, Stanislav Dikiy, Priyadarshini Chatterjee et al.
bioRxiv (Cold Spring Harbor Laboratory)
Psoriasis: Treatment and Pathogenesis
preprint

Pharmacologic IRE1 Activation Rewires Cholesterol Metabolism to Suppress TH17 Differentiation

William A. Dion, Sergei Kutseikin, Stanislav Dikiy, Priyadarshini Chatterjee, Alejandra Mendoza, R. Luke Wiseman, Prakhyat Mathur, Jessica E. Thaxton, Jie Sun, Meera Pannikkat, Keishla Sánchez Ortiz, Taylor Basso
preprint en

Abstract

T helper 17 (TH17) cells are a subset of CD4⁺ T cells that coordinate immune responses against extracellular bacterial and fungal pathogens. Dysregulation of TH17 cell responses drives excessive inflammation and contributes to the development of chronic inflammatory and autoimmune diseases, including psoriasis, inflammatory bowel disease, and multiple sclerosis. Here, we demonstrate that pharmacologic activation of the IRE1 signaling arm of the unfolded protein response (UPR) selectively reduces differentiation of TH17 cells without impacting the differentiation of other helper T cell subsets. We show that IRE1 activation suppresses TH17 differentiation by limiting intracellular cholesterol in differentiating TH17 cells through the increased degradation of the rate-limiting cholesterol biosynthesis enzyme HMGCR. Our findings identify IRE1 as a metabolic checkpoint regulating cholesterol biosynthesis in differentiating TH17 cells and demonstrate that its pharmacological activation suppresses TH17 differentiation, highlighting a potential therapeutic strategy for limiting TH17-driven inflammatory diseases.

bioRxiv (Cold Spring Harbor Laboratory)
Scripps Research Institute (US)
Conrad Prebys Foundation, American Diabetes Association, Cancer Research Institute, American Heart Association, National Institutes of Health
Good health and well-being
Psoriasis: Treatment and Pathogenesis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon